Phase II data on Lp(a) lowering, followed by NHLBI recommendation
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- The Imminent danger of Lp(a): Time to face to challengeLDL vs Lp(a) cholesterol: confounding
Calvin Yeang, MD, PhD
- The Imminent danger of Lp(a): Time to face to challengeAre we ready for prime-time Lp(a) assay standardization?
Prof. Santica Marcovina
- The Imminent danger of Lp(a): Time to face to challengeEntry of Lp(a) into the CV arena
Prof. Florian Kronenberg, MD
- The Imminent danger of Lp(a): Time to face to challengeAssociations of Lp(a) with CV morbidity and mortality
Pia Kamstrup, MD, PhD